Date
28 September 2023
Generic drugs still out of reach despite effort to ensure access
Kenya's The Star writes about the launch of the Access to Medicine Foundation's first report from its Generic & Biosimilar Medicine Programme. The report profiles five major generic companies: Cipla, Hikma, Sun Pharma, Teva and Viatris. Each of the companies is assessed on their efforts to expand access to their products in low- and middle-income countries.
Direct links
The article notes that many patients in low- and middle-income countries, including Kenya, still lack access to essential medicines, despite efforts to make them available.
One of the key findings from the report is also highlighted; even if a generic product is comparatively cheaper, patients who have to pay out-of-pocket may still not be able to afford it.
Read the Foundation's report on generic and biosimilar medicine manufacturers.